Status:
UNKNOWN
Multimodal Ultrasound and Hepatocellular Response to Local Treatments
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Consecutive patients with HCC who should undergo to locoregional treatments (ablation or trans-arterial chemoembolization) according to international guidelines will be enrolled. atients will undergo ...
Detailed Description
Primary objective: To evaluate the correlation between pre-treatment ultrasound parameters (D-CEUS and elastography) and one-month response to therapy evaluated with contrast-enhanced computed tomogra...
Eligibility Criteria
Inclusion
- Inclusion Criteria adult patients with single nodule hepatocellular carcinoma detectable with B-mode ultrasound and scheduled for locoregional treatment
- Exclusion Criteria:
- liver failure
- previous treatments fo hepatocellular carcinoma
- chronic or acute heart failure
- known ipersesitivity to ultrasound contrast agent
- pregnancy and lactation
Exclusion
Key Trial Info
Start Date :
October 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05987514
Start Date
October 7 2021
End Date
June 1 2025
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Gemelli IRCCS
Roma, Italy, 00168